Scott T. Rottinghaus Enanta Pharmaceuticals Inc (ENTA) insider trading activity
Scott T. Rottinghaus is Chief Medical Officer of ENANTA PHARMACEUTICALS INC. Currently has a direct ownership of 18,784 shares of ENTA, which is worth approximately $205,684. The most recent transaction as insider was on Aug 08, 2024, when has been sold 1,466 shares (Common Stock) at a price of $12.73 per share, resulting in proceeds of $18,662. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
18.8K
13.51%
3M change
26.43%
12M change
Total Value Held
$205,684
Scott T. Rottinghaus Transaction History
STR
Scott T. Rottinghaus
Chief Medical Officer
Watertown, MA